Comparing the Quality of Life among Patients with Relapsing Remitting Multiple Sclerosis in Iraq Using Different Disease Modifying Therapies
Multiple sclerosis (MS) is a chronic, inflammatory, immune mediated disease of the central nervous system, mostly affecting young adults with mean age of 30 years, twice as high in women compared to men. The etiology of MS is not fully elucidated. MS symptoms are directly related to demyelination a...
Main Authors: | Ruaa Natiq Yahya, Ali A.Kasim, Gheyath A. Al Gawwam |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy University of Baghdad
2018-12-01
|
Series: | Iraqi Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/795 |
Similar Items
-
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
by: Aurora Zanghì, et al.
Published: (2020-02-01) -
Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
by: Rozita Doosti, et al.
Published: (2021-04-01) -
Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
by: Oliver Findling, et al.
Published: (2018-08-01) -
A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients
by: Mehrdokht Mazdeh, et al.
Published: (2019-04-01) -
Serum prolactin in patients with relapsing remitting multiple sclerosis
by: Hoda A. Alwakil, et al.
Published: (2020-07-01)